journal article·2024-09Open access

The SWELL1 Channel Promotes Ischemic Brain Damage by Mediating Neuronal Swelling and Glutamate Toxicity

Jianan Chen, Junhua Yang, Jiachen Chu, Kevin Hong Chen, Jesse Alt, Rana Rais, Zhaozhu Qiu

Advanced Science· Volume 11· Issue 36

Abstract

Abstract Cytotoxic neuronal swelling and glutamate excitotoxicity are two hallmarks of ischemic stroke. However, the underlying molecular mechanisms are not well understood. Here, it is reported that SWELL1, the essential subunit of the volume‐regulated anion channel (VRAC), plays a dual role in ischemic injury by promoting neuronal swelling and glutamate excitotoxicity. SWELL1 expression is upregulated in neurons and astrocytes after experimental stroke in mice. The neuronal SWELL1 channel is activated by intracellular hypertonicity, leading to Cl − influx‐dependent cytotoxic neuronal swelling and subsequent cell death. Additionally, the SWELL1 channel in astrocytes mediates pathological glutamate release, indicated by increases in neuronal slow inward current frequency and tonic NMDAR current. Pharmacologically, targeting VRAC with a new inhibitor, an FDA‐approved drug Dicumarol, attenuated cytotoxic neuronal swelling and cell death, reduced astrocytic glutamate release, and provided significant neuroprotection in mice when administered either before or after ischemia. Therefore, these findings uncover the pleiotropic effects of the SWELL1 channel in neurons and astrocytes in the pathogenesis of ischemic stroke and provide proof of concept for therapeutically targeting it in this disease.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Neuroscience and Neuropharmacology Research · S100 Proteins and Annexins · Connexins and lens biology

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Physiology Johns Hopkins University School of Medicine Baltimore MD 21205 USA

Nanozyme Medical Center School of Basic Medical Sciences Zhengzhou University Zhengzhou 450001 China

Department of Veterinary Integrative Biosciences School of Veterinary Medicine and Biomedical Sciences Texas A&M University College Station Texas TX 77843 USA

Johns Hopkins Drug Discovery Johns Hopkins University School of Medicine Baltimore MD 21205 USA

Solomon H. Snyder Department of Neuroscience Department of Neurosurgery Johns Hopkins University School of Medicine Baltimore MD 21205 USA

Funding

National Institute of General Medical Sciences · National Natural Science Foundation of China · National Institute of Neurological Disorders and Stroke · American Heart Association

References (59)

Show source-provided references
1. 10.1016/S1474-4422(16)30073-410.1016/S1474-4422(16)30073-4 ↗
2. 10.1016/j.neuron.2010.07.00210.1016/j.neuron.2010.07.002 ↗
3. 10.1016/j.neuron.2015.05.04110.1016/j.neuron.2015.05.041 ↗
4. 10.1016/S0140-6736(14)60584-510.1016/S0140-6736(14)60584-5 ↗
5. 10.1001/jama.2016.1364710.1001/jama.2016.13647 ↗
6. 10.1038/s41572-019-0118-810.1038/s41572-019-0118-8 ↗
7. 10.1038/s41582-021-00605-610.1038/s41582-021-00605-6 ↗
8. 10.1054/jocn.2001.103110.1054/jocn.2001.1031 ↗
9. 10.3171/foc.2007.22.5.310.3171/foc.2007.22.5.3 ↗
10. 10.1016/j.cell.2015.03.02910.1016/j.cell.2015.03.029 ↗
11. 10.1172/JCI13479310.1172/JCI134793 ↗
12. Inoue H. · J. Neurosci. · 2007 · 27 · 144
13. 10.1161/01.STR.0000124127.57946.a110.1161/01.STR.0000124127.57946.a1 ↗
14. 10.1002/jnr.2127910.1002/jnr.21279 ↗
15. 10.1016/j.expneurol.2007.11.02710.1016/j.expneurol.2007.11.027 ↗
16. 10.1038/aps.2012.14810.1038/aps.2012.148 ↗
17. 10.1016/j.cell.2014.03.02410.1016/j.cell.2014.03.024 ↗
18. 10.1126/science.125282610.1126/science.1252826 ↗
19. 10.1016/bs.ctm.2018.07.00510.1016/bs.ctm.2018.07.005 ↗
20. 10.3389/fncel.2020.0005110.3389/fncel.2020.00051 ↗
21. 10.1016/j.neuron.2019.03.02910.1016/j.neuron.2019.03.029 ↗
22. 10.1016/j.isci.2023.10666910.1016/j.isci.2023.106669 ↗
23. 10.1016/j.expneurol.2020.11339110.1016/j.expneurol.2020.113391 ↗
24. 10.1096/fj.202002745R10.1096/fj.202002745R ↗
25. 10.1038/nm139010.1038/nm1390 ↗
26. 10.1038/aps.2012.9510.1038/aps.2012.95 ↗
27. 10.3389/fgene.2019.0081410.3389/fgene.2019.00814 ↗
28. 10.3390/cells1007163910.3390/cells10071639 ↗
29. 10.1002/dvg.2025610.1002/dvg.20256 ↗
30. 10.1523/JNEUROSCI.0567-11.201110.1523/JNEUROSCI.0567-11.2011 ↗
31. 10.1002/glia.2415610.1002/glia.24156 ↗
32. 10.1038/nrm.2016.2910.1038/nrm.2016.29 ↗
33. 10.1016/j.neuron.2004.08.01110.1016/j.neuron.2004.08.011 ↗
34. 10.1126/science.257315310.1126/science.2573153 ↗
35. Chu J. · bioRxiv · 2023 · 9
36. 10.3389/fphar.2017.0032810.3389/fphar.2017.00328 ↗
37. 10.1124/mol.112.08045710.1124/mol.112.080457 ↗
38. 10.1021/acschemneuro.9b0001010.1021/acschemneuro.9b00010 ↗
39. 10.1007/s00424-016-1794-910.1007/s00424-016-1794-9 ↗
40. 10.1002/glia.2075410.1002/glia.20754 ↗
41. 10.1113/jphysiol.2007.13037710.1113/jphysiol.2007.130377 ↗
42. Norn S. · Dan Medicinhist Arbog · 2014 · 42 · 99
43. 10.1111/j.1651-2227.2006.tb02309.x10.1111/j.1651-2227.2006.tb02309.x ↗
44. 10.1016/j.neuroscience.2020.07.01910.1016/j.neuroscience.2020.07.019 ↗
45. 10.1016/j.jneumeth.2008.12.02810.1016/j.jneumeth.2008.12.028 ↗
46. 10.1016/S1474-4422(16)00114-910.1016/S1474-4422(16)00114-9 ↗
47. 10.1016/j.tips.2011.08.00310.1016/j.tips.2011.08.003 ↗
48. 10.1084/jem.2016167310.1084/jem.20161673 ↗
49. 10.1016/j.pneurobio.2013.11.00610.1016/j.pneurobio.2013.11.006 ↗
50. 10.1038/nrn280310.1038/nrn2803 ↗
51. 10.1016/j.neuint.2007.06.00510.1016/j.neuint.2007.06.005 ↗
52. 10.1523/JNEUROSCI.23-04-01320.200310.1523/JNEUROSCI.23-04-01320.2003 ↗
53. 10.1523/JNEUROSCI.23-09-03588.200310.1523/JNEUROSCI.23-09-03588.2003 ↗
54. 10.1111/j.1469-7793.1999.783ad.x10.1111/j.1469-7793.1999.783ad.x ↗
55. 10.1161/STR.000000000000037510.1161/STR.0000000000000375 ↗
56. 10.2147/CIA.S3781810.2147/CIA.S37818 ↗
57. 10.1016/j.drudis.2020.01.00710.1016/j.drudis.2020.01.007 ↗
58. 10.1007/s13311-017-0520-410.1007/s13311-017-0520-4 ↗
59. 10.1016/j.jneumeth.2009.12.02010.1016/j.jneumeth.2009.12.020 ↗